Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,525.6
-3.0 (-0.12%)

 

  • STI Straits Times Index
    2,525.6
    -3.0 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,492.4
    -18.6 (-1.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,754.4
    184.9 (0.75%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,325.0
    -3.1 (-0.09%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,639.5
    72.4 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,096.4
    -3.4 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,157.0M
  • Value: 1,230.6M
  • Rise: 129
  • Fall: 169
  • Unch: 482

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.079-0.001
Sembcorp Marine0.140-0.001
Oceanus^0.007-
QT Vascular0.009-
ThaiBev0.580+0.005
Medtecs Intl1.190-0.080
Mapletree Log Tr2.110+0.030
Genting Sing0.665-0.005
UGHealthcare0.925-0.075
China Star Food0.026-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AURINIA PHARMACEUTICALS INC AURINIA PHARMACEUTICALS
Updated on 20 Oct 2020 (End of trading day)
Last (USD): 15.310 Change: -0.270 High: 15.750 Remarks: -
Change (%): -1.73 Low: 15.073
Open 15.600 Yesterday's Close 15.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 662,794 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.98094 Trailing EPS (USD) e -1.12130 NAV (USD) b 1.8933
PE a - Trailing PE f - Price / NAV b 8.0864
Dividend (USD) d - Cash In Hand (USD) g 1.8409 Issued & Paid-up Shares c 126,252,000
Dividend Yield (%) d - Price / Cash In Hand g 8.317 Treasury Shares h -
Market Cap (M) 1,932.918 Enterprise Value (M) 1,674.770
Piotroski F Score 2 Exchange Code AUPH Par Value ( $ ) n.a.
52 Weeks Volatility (%) 89.43 Free Float (%) 86.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 May 2016.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AURINIA PHARMACEUTICALS INC NASDAQ 1,932.918 - - 8.0864 -
Industry Biotechnology NASDAQ 2,710.381 563.107 6455.431 6.8962 0.645
Local Peer AMGEN INC NASDAQ 135,353.883 17.260 18.544 12.6986 2.534
Local Peer GILEAD SCIENCES INC NASDAQ 75,912.746 14.094 - 4.2111 4.203
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,348.802 28.996 20.563 6.7733 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,880.590 47.485 26.856 7.4317 -
Local Peer ILLUMINA INC NASDAQ 46,899.598 46.806 67.676 10.2782 -
Local Peer BIOGEN INC NASDAQ 42,288.569 7.182 7.135 3.7395 -
Local Peer SEAGEN INC NASDAQ 34,454.886 - - 18.9931 -
Local Peer MODERNA INC NASDAQ 28,137.999 - - 9.5484 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 27,180.537 - - 10.7167 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,177.452 11.304 32.121 2.5906 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 22,471.623 - - 33.2394 -
Local Peer IMMUNOMEDICS INC NASDAQ 20,277.092 - - 34.1762 -
Other Local Peers INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ARRAY TECHNOLOGIES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), VAXCYTE INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), UNIQURE N.V. (NASDAQ), VIELA BIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), REGENXBIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), NKARTA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), NANTKWEST INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), PRECIGEN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), ALECTOR INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), HUMANIGEN INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKOUOS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), AVROBIO INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATRECA INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ARDELYX INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVID BIOSERVICES INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PROTHENA CORP PLC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ONCORUS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NEXTCURE INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CABALETTA BIO INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AFFIMED N V (NASDAQ), ADICET BIO INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), MEDICINOVA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CHIASMA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SESEN BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), INMUNE BIO INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), EVOGENE LTD (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), BIOVIE INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), COHBAR INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VACCINEX INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADVAXIS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIOCARDIA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HISTOGEN INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 135,180.389 43.102 43.102 14.2586 0.988
Global Peer WUXI BIO HKEx 302,387.343 263.044 210.005 20.2429 -
Global Peer BEIGENE HKEx 215,967.726 - - 10.9866 -
Global Peer SINO BIOPHARM HKEx 151,546.978 49.376 55.104 4.3892 0.661
Global Peer ZAI LAB-SB HKEx 58,009.230 - - 16.0799 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,118.367 93.915 30.055 4.2696 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 22,465.187 - - 3.0726 -
Global Peer 3SBIO HKEx 21,366.240 19.351 14.230 1.8266 -
Global Peer ALPHAMAB-B HKEx 14,860.763 - - 5.2482 -
Other Global Peers VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), DPHARMA (Bursa), KADMON HLDGS INC (NYSE), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), KINTOR PHARMA-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), NANOVIRICIDES INC (NYSE American), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), 22ND CENTURY GROUP INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), IMMUTEP LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), MEMPHASYS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), CT ENTERPRISE (HKEx), BIOTRON (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), REGENT PACIFIC (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), REGENEUS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ORAGENICS INC (NYSE American), AMPLIA THERAPEUTICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.270
-1.73 %
10 Days --0.170
-1.10 %
20 Days -+1.210
+8.58 %
Medium Term Return 3 Months --1.350
-8.10 %
6 Months --0.800
-4.97 %
1 Year -+10.430
+213.73 %
Long Term Return 2 Years -+10.230
+201.38 %
3 Years -+9.490
+163.06 %
5 Years -+12.310
+410.33 %
Annualised Return Annualised --
+38.54 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.570 - 21.930 Change From 1 Year Low +10.740 % Change From 1 Year Low (%) +235.01
Change From 1 Year High -6.620 % Change From 1 Year High (%) -30.19
2 Years Range 3.520 - 21.930 Change From 2 Years Low +11.790 % Change From 2 Years Low (%) +334.94
Change From 2 Years High -6.620 % Change From 2 Years High (%) -30.19
5 Years Range 1.420 - 21.930 Change From 5 Years Low +13.890 % Change From 5 Years Low (%) +978.17
Change From 5 Years High -6.620 % Change From 5 Years High (%) -30.19
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Oct 2020 15.600 15.750 15.073 15.310 662,794 -
19 Oct 2020 15.630 15.750 15.500 15.580 434,946 -
16 Oct 2020 15.610 15.810 15.490 15.490 355,639 -
15 Oct 2020 15.440 15.580 15.140 15.550 528,105 -
14 Oct 2020 15.740 15.770 15.400 15.580 486,658 -
13 Oct 2020 15.650 15.750 15.420 15.670 536,244 -
12 Oct 2020 15.840 15.860 15.503 15.700 556,475 -
09 Oct 2020 15.710 15.870 15.470 15.680 551,536 -
08 Oct 2020 15.500 15.700 15.430 15.500 760,098 -
07 Oct 2020 15.780 15.780 15.150 15.480 1,289,275 -
06 Oct 2020 14.990 15.970 14.990 15.220 1,848,315 -
05 Oct 2020 14.160 15.050 14.110 15.000 1,322,510 -
02 Oct 2020 14.400 14.580 14.020 14.040 985,248 -
01 Oct 2020 14.790 14.900 14.460 14.630 998,217 -
30 Sep 2020 14.530 14.890 14.490 14.730 871,815 -
29 Sep 2020 14.360 14.660 14.300 14.560 666,409 -
28 Sep 2020 14.360 14.520 14.170 14.360 571,383 -
25 Sep 2020 14.010 14.440 13.970 14.250 466,330 -
24 Sep 2020 13.960 14.105 13.650 14.040 903,436 -
23 Sep 2020 14.860 14.860 14.070 14.100 881,857 -
22 Sep 2020 15.000 15.010 14.170 14.820 1,047,850 -
21 Sep 2020 15.400 15.400 14.660 14.900 1,330,200 -
Summary
Current 2 Weeks
(07 Oct 2020 to 20 Oct 2020)
15.780 15.870 15.073 15.310 6,161,770 -
Previous 2 Weeks
(23 Sep 2020 to 06 Oct 2020)
14.860 15.870 14.070 15.220 9,515,520 -
4 Weeks from
(25 Aug 2020 to 22 Sep 2020)
14.000 15.870 13.440 14.820 19,811,049 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.